The aim of this study was to evaluate the prognostic impact of the expression of the chemokine SDF-1 and its receptors CXCR4 and CXCR7 in patients with renal cell carcinoma. This evidence concerns the gene ACKR3 and hereditary clear cell renal cell carcinoma.